This is a community-generated profile. If you would like to claim it, please .
DiscoverStartupsSyndax Pharmaceuticals
Syndax Pharmaceuticals company logo
Syndax Pharmaceuticals
Actively Hiring
Cancer and tumor treatment development201-500 Employees

Syndax Pharmaceuticals careers

Cancer and tumor treatment development
Syndax Pharmaceuticals is a clinical-stage pharmaceutical company that focuses on an HDAC inhibitor for solid tumors and hematological tumors. It offers therapies to treat solid tumors and lung, breast, and hematological cancer. The company is developing axatilimab, a monoclonal antibody that blocks the colony-stimulating factor 1 (CSF-1) receptor, in development for chronic Graft versus Host Disease, and entinostat, a class I HDAC inhibitor. Syndax Pharmaceuticals pipeline includes and SNDX-5613, a highly selective inhibitor of the Menin–MLL binding interaction, in development for the treatment of patients with MLLr and NPM1 acute leukemias.
yesterday
AbdulQuadri Mahmud Adeyemi
Avatar for AbdulQuadri Mahmud Adeyemi
Frontend Engineer skilled in React, Next.js, TailwindCSS, and the MERN stack. I build fast, responsive web interfaces with clean, maintainable code.
Kate Biernat
Avatar for Kate Biernat
As an Executive Assistant in Biotech, I bring a unique combination of skills and expertise that go beyond traditional administrative support.
Fabrice Egros
Avatar for Fabrice Egros
senior pharmaceutical executive
Valuation

$0

Funded over

4 rounds

Latest round

Series C (Aug 2015)